Michael Andrew Pfeffer, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Informatics | 3 | 2018 | 733 | 0.790 |
Why?
|
| Hematology | 1 | 2023 | 241 | 0.680 |
Why?
|
| Hematologic Diseases | 1 | 2023 | 497 | 0.660 |
Why?
|
| Medical Records | 1 | 2023 | 1407 | 0.600 |
Why?
|
| Medicine | 2 | 2023 | 943 | 0.510 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 528 | 0.510 |
Why?
|
| Radiology | 2 | 2020 | 2103 | 0.460 |
Why?
|
| Demography | 1 | 2019 | 1650 | 0.450 |
Why?
|
| Language | 1 | 2023 | 1532 | 0.450 |
Why?
|
| Models, Organizational | 1 | 2016 | 545 | 0.420 |
Why?
|
| Thrombosis | 2 | 2023 | 3053 | 0.410 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 1118 | 0.350 |
Why?
|
| Artificial Intelligence | 4 | 2024 | 2554 | 0.320 |
Why?
|
| Electronic Health Records | 5 | 2020 | 4762 | 0.310 |
Why?
|
| Asymptomatic Diseases | 2 | 2021 | 582 | 0.290 |
Why?
|
| Leadership | 1 | 2016 | 1372 | 0.270 |
Why?
|
| Neoplasms | 3 | 2023 | 22066 | 0.260 |
Why?
|
| Decision Making | 1 | 2019 | 3924 | 0.240 |
Why?
|
| Factor XI | 1 | 2023 | 34 | 0.220 |
Why?
|
| Academic Medical Centers | 3 | 2024 | 2753 | 0.210 |
Why?
|
| Guidelines as Topic | 2 | 2019 | 1395 | 0.210 |
Why?
|
| Hirudins | 1 | 2023 | 194 | 0.210 |
Why?
|
| Hematologic Tests | 1 | 2023 | 238 | 0.200 |
Why?
|
| Computer Security | 2 | 2023 | 260 | 0.190 |
Why?
|
| Catheters | 1 | 2023 | 426 | 0.180 |
Why?
|
| Research Report | 1 | 2022 | 370 | 0.160 |
Why?
|
| Attitude to Computers | 1 | 2019 | 195 | 0.160 |
Why?
|
| Schools, Medical | 1 | 2023 | 878 | 0.140 |
Why?
|
| Cough | 1 | 2020 | 595 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 11341 | 0.130 |
Why?
|
| Access to Information | 1 | 2018 | 320 | 0.130 |
Why?
|
| Confidentiality | 1 | 2019 | 610 | 0.120 |
Why?
|
| Perioperative Period | 1 | 2016 | 265 | 0.120 |
Why?
|
| Medical Record Linkage | 1 | 2016 | 289 | 0.120 |
Why?
|
| Hemorrhage | 2 | 2023 | 3606 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3333 | 0.120 |
Why?
|
| Practice Management, Medical | 1 | 2016 | 191 | 0.120 |
Why?
|
| Organizational Objectives | 1 | 2016 | 429 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2018 | 2295 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2020 | 1032 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 1456 | 0.100 |
Why?
|
| Radiation Oncology | 1 | 2018 | 563 | 0.100 |
Why?
|
| Organizational Culture | 1 | 2016 | 506 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2019 | 1402 | 0.100 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1228 | 0.100 |
Why?
|
| Minority Groups | 1 | 2018 | 1199 | 0.090 |
Why?
|
| Macrophages, Alveolar | 2 | 2011 | 410 | 0.090 |
Why?
|
| Data Mining | 1 | 2016 | 553 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 173 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2023 | 6210 | 0.090 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 1162 | 0.090 |
Why?
|
| Patient Participation | 1 | 2019 | 1437 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1673 | 0.080 |
Why?
|
| Humans | 22 | 2024 | 760276 | 0.080 |
Why?
|
| Leukotriene B4 | 1 | 2010 | 281 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2020 | 1292 | 0.080 |
Why?
|
| Eicosanoids | 1 | 2011 | 278 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 1 | 2019 | 2528 | 0.080 |
Why?
|
| Anxiety | 1 | 2023 | 4532 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5201 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2018 | 5867 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2020 | 3811 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2022 | 5072 | 0.070 |
Why?
|
| Lipoxins | 1 | 2010 | 418 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 580 | 0.070 |
Why?
|
| Health Personnel | 1 | 2021 | 3310 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3871 | 0.070 |
Why?
|
| California | 2 | 2021 | 1416 | 0.070 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2006 | 20 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 2 | 2024 | 926 | 0.070 |
Why?
|
| Lung Injury | 1 | 2011 | 424 | 0.070 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2006 | 38 | 0.070 |
Why?
|
| Hospitals | 1 | 2019 | 3930 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 3526 | 0.060 |
Why?
|
| Docosahexaenoic Acids | 1 | 2012 | 912 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5324 | 0.060 |
Why?
|
| Students, Medical | 1 | 2018 | 1926 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3242 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3216 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4361 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2024 | 54265 | 0.060 |
Why?
|
| Algorithms | 1 | 2024 | 13959 | 0.060 |
Why?
|
| United States | 4 | 2024 | 72369 | 0.060 |
Why?
|
| Pandemics | 2 | 2020 | 8621 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2012 | 1159 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2010 | 1927 | 0.050 |
Why?
|
| Male | 10 | 2020 | 359427 | 0.050 |
Why?
|
| Asthma | 2 | 2012 | 6167 | 0.050 |
Why?
|
| Middle Aged | 8 | 2020 | 220179 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1882 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 1870 | 0.050 |
Why?
|
| Physicians | 1 | 2019 | 4590 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 8022 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 617 | 0.040 |
Why?
|
| Female | 8 | 2020 | 391024 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9946 | 0.040 |
Why?
|
| Los Angeles | 1 | 2017 | 243 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2017 | 301 | 0.030 |
Why?
|
| Heparin | 1 | 2023 | 1656 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 11836 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2023 | 80311 | 0.030 |
Why?
|
| Seasons | 1 | 2020 | 1523 | 0.030 |
Why?
|
| Health Care Reform | 1 | 2023 | 1245 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 6543 | 0.030 |
Why?
|
| Certification | 1 | 2017 | 423 | 0.030 |
Why?
|
| Data Collection | 1 | 2022 | 3317 | 0.030 |
Why?
|
| Aged | 3 | 2019 | 169002 | 0.020 |
Why?
|
| Hydrochloric Acid | 1 | 2011 | 76 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2023 | 5120 | 0.020 |
Why?
|
| Adult | 6 | 2023 | 219843 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 750 | 0.020 |
Why?
|
| Acute Disease | 1 | 2020 | 7268 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 663 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3360 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2311 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 1765 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2023 | 4899 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1697 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1705 | 0.020 |
Why?
|
| Cytokines | 2 | 2012 | 7346 | 0.020 |
Why?
|
| Internet | 1 | 2018 | 3074 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 1822 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2006 | 181 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2010 | 1810 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4573 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 5039 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2010 | 908 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20045 | 0.010 |
Why?
|
| Curriculum | 1 | 2017 | 3722 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15684 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2010 | 2919 | 0.010 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 2214 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 29640 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 21379 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2016 | 3840 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7809 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10761 | 0.010 |
Why?
|
| Aspirin | 1 | 2012 | 3365 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3604 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11064 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39256 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 58673 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40141 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 2136 | 0.010 |
Why?
|
| Macrophages | 1 | 2012 | 5746 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 1902 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41316 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9390 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 81212 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13456 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2006 | 3046 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58953 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17628 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18135 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11902 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74278 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 22040 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15828 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 167935 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 23366 | 0.000 |
Why?
|
| Mutation | 1 | 2011 | 29951 | 0.000 |
Why?
|
| Inflammation | 1 | 2006 | 10758 | 0.000 |
Why?
|